Covered recipient · General Payments record
DANIEL T FRIEDMAN
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$1,392.19
- Reported across 33 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $325.39 | 15 |
| Education | $83.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SOBI, INC | $99.18 | 5 |
| Incyte Corporation | $83.99 | 1 |
| GENZYME CORPORATION | $40.10 | 2 |
| JAZZ PHARMACEUTICALS INC. | $38.41 | 1 |
| Celgene Corporation | $29.15 | 2 |
| Merck Sharp & Dohme Corporation | $28.71 | 1 |
| Janssen Biotech, Inc. | $27.79 | 1 |
| ABBVIE INC. | $26.76 | 1 |
| Acerta Pharma LLC | $20.11 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.76 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103755785 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.11 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105544907 | CMS |
| Celgene Corporation | $13.20 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101080123 | CMS |
| Celgene Corporation | $15.95 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101080127 | CMS |
| GENZYME CORPORATION | $23.34 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139817897 | CMS |
| GENZYME CORPORATION | $16.76 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139817973 | CMS |
| Incyte Corporation | $83.99 | 10/16/2024 | Education | Undisputed | 01/23/2026 | 1141303929 | CMS |
| Janssen Biotech, Inc. | $27.79 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078407021 | CMS |
| JAZZ PHARMACEUTICALS INC. | $38.41 | 06/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150219583 | CMS |
| Merck Sharp & Dohme LLC | $28.71 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141722758 | CMS |
| Novartis Pharmaceuticals Corporation | $15.18 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086881363 | CMS |
| SOBI, INC | $19.23 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141438093 | CMS |
| SOBI, INC | $22.61 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141438259 | CMS |
| SOBI, INC | $19.82 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141438261 | CMS |
| SOBI, INC | $15.02 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141438295 | CMS |
| SOBI, INC | $22.50 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141438759 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.